Bio-View Ltd (TLV:BIOV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
23.20
-2.40 (-9.38%)
Aug 5, 2025, 2:56 PM IDT

Bio-View Company Description

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally.

The company’s products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH and Karyotype samples in real-time; and Allegro Plus, an automatic imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions.

It also offers DUET-3, an automated imaging system that supports multiple applications; Encore, an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; Solo Touch Workstation, a stand-alone workstation that streamlines review and analysis of test results away from the microscope; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases.

Bio-View Ltd has a partnership agreement with ANGLE plc to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer.

The company was incorporated in 1998 and is headquartered in Rehovot, Israel.

Bio-View Ltd
Bio-View logo
CountryIsrael
Founded1998
IndustryMedical Devices
SectorHealthcare
Employees33
CEODaniel Klain

Contact Details

Address:
3 Pekeris Street
Rehovot, 7670203
Israel
Phone972 73 227 1025
Websitebioview.com

Stock Details

Ticker SymbolBIOV
ExchangeTel Aviv Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyILS
ISIN NumberIL0010960495
SIC Code3845

Key Executives

NamePosition
Yuval Harari M.Sc.Deputy Chief Executive Officer
Daniel KlainChief Executive Officer
Inbal Shmula HillelVice President of Operations
Elad KafirVice President of Marketing and Sales
Liat BidsBusiness Development Manager and Director
David KutasNorth American Operations Manager
Atiya PineVice President of Finance and Chief Financial Officer